Please provide your email address to receive an email when new articles are posted on . Epinephrine autoinjectors were provided by 57% of emergency medical services. 97% of states recommended ...
BOSTON (Oct. 24, 2024) – Anaphylaxis can come on suddenly and without warning, and because its symptoms can be fatal, it is scary for those who encounter it. Two new studies being presented at this ...
Older adults who present to the emergency department (ED) with anaphylaxis may be more likely than younger adults to be hospitalized and to have medications or intravenous contrast as triggers, a ...
An EpiPen is a device used to quickly deliver the medication epinephrine to someone who’s experiencing anaphylaxis. Anaphylaxis is a severe and potentially life threatening consequence of an allergic ...
Anaphylaxis symptoms might subside after epinephrine treatment, but they could return, even hours later. Always go to the ER after an anaphylactic reaction in case you need follow-up care. There are ...
November 18, 2009 (Miami, Florida) — Although all 50 states allow some level of their emergency medical services (EMS) staff to carry either epinephrine (Epi) autoinjectors or vials, only about two ...
MIDDLETOWN — Students enrolled in the emergency medical technician course at Middlesex Community College are among the first in the state to learn how to administer intramuscular epinephrine by ...
Anaphylaxis is a severe allergic reaction that usually affects multiple areas of the body at once. Sam Torbati, MD, a cochair and the medical director of the emergency department at Cedars-Sinai in ...
Washington, DC, Aug. 27, 2025 (GLOBE NEWSWIRE) -- The Asthma and Allergy Foundation of America (AAFA) announces the availability of the first validated food allergy anaphylaxis action plan, including ...
You can save your own or another person's life if you know how to prevent and treat anaphylaxis, a serious type of allergic reaction. If you know that you’re at risk for anaphylaxis, work with your ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results